Disease Score gda Association Type Type Original DB Sentence supporting the association PMID PMID Year
CUI: C0004096
Disease: Asthma
Asthma
0.290 GeneticVariation disease BEFREE Furthermore, having TG + GG genotypes on rs1031509 near STAT4 was associated with 5-times (95% CI, 3.03-8.55) greater odds of asthma diagnosis at the highest B[a]P range, compared to the odds at the reference range. 28807506 2017
CUI: C0004096
Disease: Asthma
Asthma
0.290 GeneticVariation disease BEFREE Therapeutic implication of genetic variants of IL13 and STAT4 in airway remodelling with bronchial asthma. 26765219 2016
CUI: C0004096
Disease: Asthma
Asthma
0.290 Biomarker disease BEFREE In conclusion, our studies led to identification of some key candidate genes, namely IRF2, IL6, IFNGR2, STAT4 and IL4RA that modulate genetic susceptibility to asthma in the Indian population. 25994869 2015
CUI: C0004096
Disease: Asthma
Asthma
0.290 Biomarker disease BEFREE After correction for multiple comparisons, 7 SNPs in 6 genes (CARD25, TGFB1, LY96, ACAA1, DEFB1, and IFNG) were associated with asthma (adjusted p-value<0.02), while 5 SNPs in 3 different genes (CD80, STAT4, and IRAKI) were significantly associated with eczema (adjusted p-value < 0.02). 22192168 2012
CUI: C0004096
Disease: Asthma
Asthma
0.290 Biomarker disease BEFREE OVA-challenged STAT4-/- mice exhibited elevated AHR and pulmonary eosinophilia. 21205293 2011
CUI: C0004096
Disease: Asthma
Asthma
0.290 Therapeutic disease RGD 20 +/- 1.75)%] were all significantly higher than those of the control group [(1.51 +/- 1.04) x 10(7)/L, (0.70 +/- 0.48)%] (P < 0.01); the total cell numbers in BALF, the absolute numbers of EOS and EOS% of RA groups [(14.89 +/- 2.35) x 10(7)/L, (4.70 +/- 0.82)%; (10.98 +/- 1.81) x 10(7)/L, (3.56 +/- 0.53)%] were all significantly lower than those of asthma group (P < 0.01); (2) The concentration of IL-4 in BALF of asthma group (25.70 +/- 7.36) was significantly higher than that of the control group (8.55 +/- 2.97) (P < 0.01); the concentration of IL-4 of BALF of RA groups [(31.89 +/- 5.46), (35.26 +/- 6.03)] was significantly lower than that of asthma group (P < 0.01); the concentration of IL-12 of BALF of asthma group (16.10 +/- 3.38) was significantly lower than that of the control group (42.33 +/- 9.66) (P < 0.01); the concentration of IL-12 of BALF of the RA groups [(31.89 +/- 5.46), (35.26 +/- 6.03)] was significantly higher than that of the asthma group (P < 0.01); (3) Immunohistochemistry and in situ hybridization showed that the protein content of STAT4 and the STAT4 mRNA expression around the bronchus of asthma group [(0.096 +/- 0.012), (0.098 +/- 0.011)] were lower than those of the control group [(0.216 +/- 0.034), (0.228 +/- 0.032)], while those of RA groups [(0.176 +/- 0.012), (0.185 +/- 0.023); (0.183 +/- 0.011), (0.201 +/- 0.019)] were all significantly higher than that of the asthma group (P < 0.01), the airway smooth muscle cells, the pulmonary arterial smooth muscle cells and endothelial cells were the chief expression cells; (4) the STAT4 and the STAT4mRNA expression around the bronchus had positive correlation with the concentration of IL-12 in BALF while had negative correlation with the concentration of IL-4, absolute numbers of EOS in BALF. 18211752 2007
CUI: C0004096
Disease: Asthma
Asthma
0.290 GeneticVariation disease LHGDN The STAT-4 T90089C polymorphisms were significantly associated with asthma in the dominant model (p=0.007). 17532201 2007
CUI: C0004096
Disease: Asthma
Asthma
0.290 GeneticVariation disease BEFREE The STAT-4 T90089C polymorphisms were significantly associated with asthma in the dominant model (p=0.007). 17532201 2007
CUI: C0004096
Disease: Asthma
Asthma
0.290 GeneticVariation disease BEFREE In an effort to discover additional polymorphism(s) in genes in which variant(s) have been implicated in asthma, we investigated the genetic polymorphisms in STAT4 to evaluate it as a potential candidate gene for a host genetic study of asthma. 15744455 2005
CUI: C0004096
Disease: Asthma
Asthma
0.290 GeneticVariation disease BEFREE However, genomic DNA isolated from 91 patients with asthma or rheumatoid arthritis showed no evidence of mutations in the defined STAT4 essential promoter region. 16301617 2005
CUI: C0004096
Disease: Asthma
Asthma
0.290 Biomarker disease BEFREE For STAT6 and STAT4, no significant association to asthma or serum total IgE levels was observed. 15637551 2005